Zomedica Corp. (ZOMDF)
OTCMKTS
· Delayed Price · Currency is USD
0.0994
+0.0014 (1.46%)
At close: Apr 28, 2026
Zomedica Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 32.03 | 27.29 | 25.19 | 18.93 | 4.13 | Upgrade
|
| Revenue Growth (YoY) | 17.39% | 8.33% | 33.05% | 358.02% | - | Upgrade
|
| Cost of Revenue | 10.35 | 8.2 | 7.87 | 5.46 | 1.08 | Upgrade
|
| Gross Profit | 21.68 | 19.09 | 17.32 | 13.47 | 3.05 | Upgrade
|
| Selling, General & Admin | 43.03 | 46.85 | 43.17 | 32.81 | 22.85 | Upgrade
|
| Research & Development | 7.17 | 7.27 | 5.74 | 2.58 | 1.58 | Upgrade
|
| Operating Expenses | 50.2 | 54.12 | 48.91 | 35.39 | 24.43 | Upgrade
|
| Operating Income | -28.52 | -35.03 | -31.59 | -21.92 | -21.37 | Upgrade
|
| Interest Expense | - | - | -0.18 | -0 | -0.01 | Upgrade
|
| Interest & Investment Income | 2.44 | 3.97 | 5.46 | 2.7 | 0.36 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.01 | -0.25 | 0.03 | -0.15 | -0.03 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.14 | 0.01 | -0.09 | -0.01 | 0.05 | Upgrade
|
| EBT Excluding Unusual Items | -26.24 | -31.31 | -26.38 | -19.38 | -21 | Upgrade
|
| Impairment of Goodwill | -45.56 | -16.02 | -12.2 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | 2.17 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.07 | -0.21 | 0.02 | 0 | -0.25 | Upgrade
|
| Asset Writedown | -10.28 | - | 0.51 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.53 | Upgrade
|
| Pretax Income | -82.14 | -47.54 | -35.86 | -19.38 | -20.72 | Upgrade
|
| Income Tax Expense | -0.28 | -0.56 | -1.33 | -2.37 | -2.33 | Upgrade
|
| Net Income | -81.86 | -46.98 | -34.53 | -17.02 | -18.38 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 32.04 | Upgrade
|
| Net Income to Common | -81.86 | -46.98 | -34.53 | -17.02 | -50.42 | Upgrade
|
| Shares Outstanding (Basic) | 980 | 980 | 980 | 980 | 957 | Upgrade
|
| Shares Outstanding (Diluted) | 980 | 980 | 980 | 980 | 957 | Upgrade
|
| Shares Change (YoY) | - | - | - | 2.45% | 162.46% | Upgrade
|
| EPS (Basic) | -0.08 | -0.05 | -0.04 | -0.02 | -0.05 | Upgrade
|
| EPS (Diluted) | -0.08 | -0.05 | -0.04 | -0.02 | -0.05 | Upgrade
|
| Free Cash Flow | -18.22 | -28.84 | -27.31 | -14.22 | -14.42 | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.03 | -0.03 | -0.01 | -0.01 | Upgrade
|
| Gross Margin | 67.68% | 69.95% | 68.76% | 71.15% | 73.89% | Upgrade
|
| Operating Margin | -89.04% | -128.38% | -125.44% | -115.81% | -517.15% | Upgrade
|
| Profit Margin | -255.57% | -172.19% | -137.10% | -89.88% | -1220.01% | Upgrade
|
| Free Cash Flow Margin | -56.87% | -105.71% | -108.45% | -75.12% | -348.97% | Upgrade
|
| EBITDA | -20.57 | -27.04 | -25.29 | -17.88 | -20.24 | Upgrade
|
| EBITDA Margin | -64.22% | -99.11% | -100.43% | -94.46% | - | Upgrade
|
| D&A For EBITDA | 7.95 | 7.99 | 6.3 | 4.04 | 1.14 | Upgrade
|
| EBIT | -28.52 | -35.03 | -31.59 | -21.92 | -21.37 | Upgrade
|
| EBIT Margin | -89.04% | -128.38% | -125.44% | -115.81% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.